













httpImpact of contralateral carotid or vertebral artery
occlusion in patients undergoing carotid
endarterectomy or carotid artery stenting
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Objective: To determine the impact of contralateral carotid occlusion (CCO) and/or vertebral artery occlusion (VAO) on
the development of early postoperative neurologic complications after carotid endarterectomy (CEA) or carotid artery
stenting (CAS).
Methods: A retrospective analysis was conducted using a database of patients who underwent CEA (n[ 698) or CAS (n[
455) at a single institution. Excluded were 44 CEAs synchronously performed with coronary artery bypass grafting and
76 CASs performed without an embolic protective device (n[ 69) or that resulted in technical failures (n[ 7). All CEAs
were the conventional type and performed under general anesthesia, and carotid shunts were routinely used. Patients were
categorized into three groups according to patency of the contralateral carotid and vertebral arteries: Group I (no CCO or
VAO); Group II (CCO with or without VAO); Group III (with VAO but no CCO). CCO or VAO were diagnosed with
two or more carotid imaging studies including duplex ultrasonography, computed tomography angiography, magnetic
resonance angiography, or conventional carotid angiography. Patient groups were compared with demographics,
preoperative symptomatic status, and frequencies of early (<30 days) symptomatic neurologic complications (ESNCs)
including transient ischemic attack and stroke. Postprocedural stroke alone was separately compared. Univariate (c2 or
Fisher’s exact test) and multivariate analysis (multiple logistic regression) were conducted to determine predictors of
ESNC or postprocedural stroke.
Results: ESNCs and postprocedural stroke developed signiﬁcantly more often with CAS compared with CEA (ESNC,
2.6% vs 8.1%; P < .001; stroke, 1.3% vs 6.8%; P < .001). In group II, the frequency of ESNCs was higher (6.8% vs 1.8%;
P[ .044), but the frequency of postprocedural stroke was not signiﬁcantly higher (2.3% vs 0.9%; P[ .405) in the CEA
group. By multivariate analysis, the presenting symptom of stroke (odds ratio, 3.612; 95% conﬁdence interval, 1.288-
10.130; P[ .015) and group II (odds ratio, 7.242; 95% conﬁdence interval, 1.727-30.374; P[ .007) were independent
risk factors of ESNC following CEA but not CAS. When we analyzed the risk factor for postprocedural stroke alone, the
presenting symptom of stroke was the only risk factor, while presence of CCO or VAO was not.
Conclusions: CAS was followed by a signiﬁcantly higher frequency of ESNC and postprocedural stroke compared
with CEA. By subgroup analysis, CCO was a risk factor for ESNC but not for postprocedural stroke alone in
patients undergoing CEA. Unilateral or bilateral VAO was not associated with a higher rate of ESNC or stroke in CEA
or CAS. (J Vasc Surg 2014;59:749-55.)Contralateral carotid occlusion (CCO) was present in
6% to 10% of patients undergoing carotid endarterectomy
(CEA).1 According to a study2 describing the natural
history of patients with asymptomatic carotid stenosis
($60%) and CCO, patients were associated with a higher
incidence of stroke than those without CCO. And CEA
for patients with CCO has been known to be associated
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://dx.doi.org/10.1016/j.jvs.2013.10.055The most common cause of periprocedural stroke in
CEA or carotid artery stenting (CAS) patients is throm-
boembolism. Cerebral hypoperfusion and intracranial
hemorrhage can be rare causes of stroke. Patients with
CCO or vertebral artery occlusion (VAO) theoretically
have an increased risk of intolerance to ipsilateral carotid
clamping, distal cerebral embolization, or rarely, cerebral
hyperperfusion syndrome. Reported results on the impact
of CCO in patients who undergo CEA have been
conﬂicting.5,6
The North American Symptomatic Carotid Endarter-
ectomy Trial (NASCET)7 and a recently reported meta-
analysis8 suggest that CCO is a predictor of poor outcomes
following ipsilateral CEA. In the Stenting and Angioplasty
with Protection in Patients at High Risk for Endarterec-
tomy (SAPPHIRE) trial, presence of CCO was also classi-
ﬁed as a high risk group for CEA.9 However, Rockman
et al10 reviewed previous reports and described that the
presence of CCO does not signiﬁcantly increase periopera-
tive risk in CEA. In post hoc analysis of the Asymptomatic
Carotid Atherosclerosis Study (ACAS), the perioperative749
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without CCO.11
Few reports so far have evaluated the impact of VAO
in the outcomes of CEA or CAS.12,13 The purpose of
our study was to determine the impact of CCO and/or
VAO on the development of early postoperative symptom-




Study enrollment. This study was approved by the
local Institutional Review Board of Samsung Medical
Center, Seoul, Korea. All CEAs (n ¼ 698) and CASs
(n ¼ 455) performed at a single institution between March
1995 and December 2012 were included for analysis after
excluding 44 CEAs performed in conjunction with coro-
nary artery bypass grafting and 76 CASs that were per-
formed in a period in which embolic protective devices
were not used (n ¼ 69) or that resulted in technical failures
(n ¼ 7).
Procedures. When deciding treatment modality
between CEA or CAS, CAS was selected for patients
with an unfavorable carotid anatomy, high surgical risks
for CEA, the preference of the patient, and for the purpose
of clinical trial. All CEAs were performed under general
anesthesia using conventional endarterectomy techniques,
and routinely used a carotid shunt (Pruitt-Inahara Carotid
Shunts; LeMaitre Vascular, Burlington, Mass). The carotid
artery was closed primarily (n ¼ 387; 55%) or with pro-
cessed bovine pericardial patch (n ¼ 311; 45%; Vascu-
Guard; Synnovis Surgical Innovations, St. Paul, Minn) by
the surgeon’s preference.
CASs were performed under local anesthesia using
a percutaneous femoral artery approach with preprocedural
loading of antiplatelet therapy (aspirin 100 mg/day and/or
clopidogrel 75-300 mg) and intraoperative intravenous
unfractionated heparin (50-60 units/kg body weight).
After CEA or CAS, single or dual antiplatelet therapy was
continued unless contraindicated.
Assessment of neurologic symptoms. Initial neuro-
logic symptoms at presentation were routinely evaluated
by neurologists for all symptomatic patients. For patients
complaining of unusual prolonged headache or showing
abnormal neurological signs after CEA or CAS, neurologic
examinations were performed by neurologists. Postopera-
tive diffusion-weighted brain magnetic resonance imaging
was performed in 520 (45%) patients for the purpose of
other clinical trials (32%) or postprocedural headache or
neurologic symptoms (13%). ESNCs included transient
ischemic attack (TIA) and stroke within 30 days after CEA
or CAS irrespective of site. Symptoms or signs related to
cervical nerve injury during CEA were not included in
ESNCs.
Diagnosis CCO or VAO. CCO or VAO was diag-
nosedusing twoormore carotid imaging studies. Extracranial
CCO or VAO suspected on duplex ultrasonogram wasreexaminedusingCTangiogram (CTA),magnetic resonance
angiogram (MRA), or transfemoral carotid angiography.
Data analysis
We retrospectively reviewed the patients’ database of
demographics, preoperative coexisting morbidities, and
symptomatic status of the patients. Presence of neurolog-
ical or ocular symptoms within 6 months prior to CEA
or CAS was regarded as symptomatic.
Patients were categorized into three groups by pres-
ence or absence of CCO or VAO on pretreatment imaging
studies: Group I, patients without CCO or VAO; Group
II, patients with CCO and with or without one or both
VAOs; Group III, patients with one or both VAOs but
no CCO. We compared demographic and clinical charac-
teristics between the CEA and CAS groups. To determine
the impact of CCO or VAO on the development of ESNC
or postprocedural stroke, univariate and multivariate anal-
yses were conducted comparing the frequencies of ESNC
or postprocedural stroke among the three groups accord-
ing to the treatment modalities (CEA vs CAS) and present-
ing symptomatic status.
For statistical analysis, continuous variables were pre-
sented as mean 6 standard deviation, and categorical
values were described as percentages. For statistical
comparisons, Student t-test, c2, or Fisher’s exact test and
simple logistic regression were used. In multivariate analysis
to determine independent risk factors for ESNC and post-
procedural stroke, multiple logistic regression was used. All
P values were two-sided, and statistical signiﬁcance was
deﬁned as P < .05.
RESULTS
For 487 (42%) patients with symptomatic carotid
stenosis, 253 (52%) CEAs and 234 (48%) CASs were per-
formed. For 666 (58%) patients with asymptomatic carotid
stenosis, 445 (67%) CEAs and 221 (33%) CASs were
performed.
Among 455 CAS patients, 59 (13%) had unfavorable
anatomies for CEA, which included 45 high carotid bifur-
cations, 10 previous neck dissections or radiation therapy,
and four diffuse carotid lesions extending to the proximal
common carotid artery. Sixty (13%) patients had high-
risk comorbidities, including 50 severe cardiac (New
York Heart Association class III or IV congestive heart
failure or recent myocardial infarction) and 10 severe
pulmonary comorbidities. The remaining 336 CASs were
performed for the purpose of clinical trials or patients’
preference.
Table I compares demographic and clinical features
among CEA patients in the three groups. As shown in
Table I, patients in Group II (patients with CCO) less
frequently presented with stroke (Group I, 19.6%; Group
II, 2.3%; Group III, 17.4%; P ¼ .006) and had less coexist-
ing hypertension (Group I, 76.3%; Group II, 70.5%; Group
III, 87.2%; P ¼ .022), while coexisting coronary artery
disease was more common in patients in Group II (Group
I, 36.1%; Group II, 61.4%; Group III, 44.0%; P ¼ .002).
Table II. Comparison of demographic and clinical features among carotid artery stenting (CAS) patients
Features Group I (n ¼ 336; 74%) Group II (n ¼ 50; 11%) Group III (n ¼ 69; 15%) P
Age, years
Mean 6 SD 68.8 6 7.9 67.0 6 9.6 69.5 6 8.7 .241
Range 38-92 44-88 46-88
Female 48 (14.3) 4 (8.0) 13 (18.8) .249
Symptomatic 177 (52.7) 24 (48) 33 (47.8) .678
Amaurosis fugax 12 (3.6) 0 (0) 2 (2.9) .532
TIA 49 (14.6) 13 (26.0) 12 (17.4) .118
Stroke 116 (34.5) 11 (22.0) 19 (27.5) .142
Comorbidities and risk factors
Hypertension 266 (79.2) 36 (72.0) 58 (84.1) .284
Coronary artery disease 90 (26.8) 19 (38.0) 26 (37.7) .078
Chronic kidney disease 6 (1.8) 0 (0) 3 (4.3) .225
Hyperlipidemia 225 (67.0) 36 (72.0) 38 (55.1) .101
Smoking 180 (53.6) 31 (62.0) 35 (50.7) .435
Atrial ﬁbrillation 16 (4.8) 2 (4) 6 (8.7) .383
CCO, Contralateral carotid occlusion; SD, standard deviation; TIA, transient ischemic attack; VAO, vertebral artery occlusion.
Group I, Patients without CCO or VAO; Group II, patients with CCO with or without one or both VAOs; Group III, patients with one or both VAOs
but no CCO.
Data are presented as number (%) unless otherwise stated.
Table I. Comparison of demographic and clinical features in carotid endarterectomy (CEA) patients
Features Group I (n ¼ 545; 78%) Group II (n ¼ 44; 6%) Group III (n ¼ 109; 16%) P
Age, years
Mean 6 SD 67.1 6 7.5 66.7 6 6.8 69.0 6 7.0 .036
Range 44-85 47-80 53-86
Female 73 (13.4) 3 (6.8) 10 (9.2) .260
Symptomatica 208 (38.2) 10 (22.7) 35 (32.1) .080
Amaurosis fugax 9 (1.7) 2 (4.5) 2 (1.8) .389
TIA 92 (16.9) 7 (15.9) 14 (12.8) .588
Stroke 107 (19.6) 1 (2.3) 19 (17.4) .006
Comorbidities and risk factors
Hypertension 416 (76.3) 31 (70.5) 95 (87.2) .022
Coronary artery disease 197 (36.1) 27 (61.4) 48 (44.0) .002
Chronic kidney disease 14 (2.6) 2 (4.5) 5 (4.6) .327
Hyperlipidemia 357 (65.5) 33 (75.0) 65 (59.6) .191
Smoking 312 (57.2) 30 (68.2) 56 (51.4) .169
Atrial ﬁbrillation 23 (4.2) 2 (4.5) 9 (8.3) .166
CCO, Contralateral carotid occlusion; CEA, carotid endarterectomy; Chronic kidney disease, serum creatinine >2.0 mg/dL or kidney transplantation or
dialysis; Coronary artery disease, percutaneous coronary intervention or coronary artery bypass graft before current admission or history of diagnosed
myocardial infarction or angina; Hypertension, history of hypertension diagnosed and treated with medication, diet, and/or exercise or blood pressure greater
than 140 mm Hg systolic or 90 mm Hg diastolic on at least two occasions or current use of antihypertensive pharmacological therapy; SD, standard deviation;
Stroke, acute neurologic event with focal symptoms and signs, lasting for 24 hours or longer and consistent with focal cerebral ischemia; TIA, transient ischemic
attack; VAO, vertebral artery occlusion.
Group I,Patients withoutCCO andVAO;Group II, patients withCCOwith orwithout one or both VAOs;Group III, patients with one or both VAOs but noCCO.
Data are presented as number (%) unless otherwise stated.
aSymptomatic, presence of neurologic or ocular symptoms within 6 months before CEA.
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of CAS patients in the three groups and shows no signiﬁcant
difference in age, gender, or symptomatic status. However,
diabetes mellitus was more frequent in Group III (Group I,
41.4%; Group II, 48%; Group III, 58%; P ¼ .036).
ESNC developed in 18 (2.6%) patients after CEA and
37 (8.1%) patients after CAS (P < .001). When we
compared postprocedural stroke alone, we found signiﬁ-
cantly higher stroke rate in CAS (1.3% for CEA vs 6.8%
for CAS; P < .001); particularly, ipsilateral stroke was
signiﬁcantly more frequent in CAS than in CEA (1.1%for CEA vs 6.2% for CAS; P < .001). When frequencies
of ESNCs after CEA or CAS were compared according
to the preoperative symptomatic status (Table III), ESNCs
were signiﬁcantly more frequent in CAS compared with
CEA either in symptomatic or asymptomatic patients.
This ﬁnding was more remarkable in patients with present-
ing symptoms of stroke. Interestingly, three hemorrhagic
strokes developed only in symptomatic patients after
CAS, not in CEA or asymptomatic CAS groups.
Fig 1 shows the comparison of frequencies of ESNCs
according to the treatment type and presence of the
Table III. Frequencies of early symptomatic neurologic complications (ESNCs) after carotid endarterectomy (CEA) or
carotid artery stenting (CAS) according to the preoperative symptomatic status
ESNC
Symptomatic patients (n ¼ 487; 42%)
P
Asymptomatic patients (n ¼ 666; 58%)
P
CEA (n ¼ 253),
No. (%)
CAS (n ¼ 234),
No. (%)
CEA (n ¼ 445),
No. (%)
CAS (n ¼ 221),
No. (%)
TIA 2 (0.8) 5 (2.1) .269 7 (1.6) 1 (0.5) .281
Stroke 6 (2.4) 16 (6.8) .018 3 (0.7) 15 (6.8) <.001
Ipsilateral infarction 6 (2.4) 12 (5.1) .107 2 (0.4) 13 (5.9) <.001
Nonipsilateral infarction 0 1 (0.4) .480 1 (0.2) 2 (0.9) .257
Hemorrhagic 0 3a (1.3) .110 0 0
Subtotal 8 (3.2) 21 (9) .007 10 (2.2) 16 (7.2) .002
TIA, Transient ischemic attack.
aHemorrhagic stroke includes one subdural, one intracerebral, and one intraventricular hemorrhage.
Fig 1. Frequencies of early symptomatic neurologic complications
(ESNCs) according to treatment type and presence of the
contralateral carotid occlusion (CCO) and/or vertebral artery
occlusion (VAO). CAS, Carotid artery stenting; CEA, carotid
endarterectomy; Group I, patients without CCO or VAO; Group
II, patients with CCO with or without one or both VAOs; Group
III, patients with one or both VAOs and without CCO; NS, not
signiﬁcant.
Fig 2. Frequencies of early postprocedural stroke rates according
to treatment type and presence or absence of contralateral carotid
occlusion (CCO) and/or vertebral artery occlusion (VAO). CAS,
Carotid artery stenting; CEA, carotid endarterectomy; Group I,
patients without CCO or VAO; Group II, patients with CCO with
or without one or both VAOs; Group III, patients with one or
both VAOs and without CCO; NS, not signiﬁcant.
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developed signiﬁcantly more often in Group II (1.8% vs
6.8%; P ¼ .044) after CEA, whereas there was no signiﬁ-
cant difference between Groups I and III (1.8% vs 4.6%;
P ¼ .091). There was no signiﬁcant difference in the
frequencies of ESNC among the three groups after CAS.
As shown in the ﬁgure, overall frequency of ESNC was
signiﬁcantly higher after CAS compared with CEA (2.6%
vs 8.1%; P < .001).
When we compared frequencies of postprocedural
stroke alone according to the treatment type and presence
or absence of CCO and/or VAO (Fig 2), we found that
overall stroke rate was signiﬁcantly higher after CAS than
CEA (6.8% vs 1.3%; P < .001), whereas we could not
ﬁnd any adverse impact of CCO or VAO on the develop-
ment of postprocedural stroke.
By multiple logistic regression analysis, presenting
symptom of stroke or Group II (presence of CCO) was an
independent risk factor for ESNC in the CEA patients but
not in CAS patients (Table IV). However, overall frequencyof ESNC was signiﬁcantly higher after CAS when compared
with CEA. Presence of VAOwithout CCO (Group III) was
not a risk factor for ESNC in the CEA group even for
patients with bilateral involvement (Table IV).
When we conducted a multivariate analysis of risk
factors for postprocedural stroke alone, presenting
symptom of stroke was only a predictor of postprocedural
stroke while presence of CCO or VAO was not (Table V).
DISCUSSION
Although CCO is often considered to be a risk factor
for postoperative stroke in patients undergoing CEA,14,15
this hypothesis is still under debate, and the impact of
CCO or VAO on CAS has not been fully understood
yet. While an impact of CCO and/or VAO on the results
of CEA or CAS was not clearly proven, CEA and CAS
are performed in current practice for patients with CCO
and/or VAO. We tried to determine the impact of CCO
and/or VAO on the development of ESNC (composite
endpoint including TIA or stroke) and postprocedural
Table IV. Logistic regression analysis of risk factors for early symptomatic neurologic complications (ESNCs)
Variable Reference of comparison
CEA (n ¼ 18; 2.6%) CAS (n ¼ 37; 8.1%)
OR (95% CI) P OR (95% CI) P
Presenting symptom
Strokea Asymptomatic 3.612 (1.288-10.130) .015 1.219 (0.596-2.496) .587
Status of contralateral carotid and vertebral artery
Group IIb Group I 7.242 (1.727-30.374) .007 0.964 (0.319-2.909) .948
Group IIIb Group I 2.908 (0.948-8.924) .062 1.053 (0.414-2.674) .914
CAS, Carotid artery stenting; CEA, carotid endarterectomy; CI, conﬁdence interval; OR, odds ratio.
Group I, Patients without CCO or VAO; Group II, patients with CCO with or without VAO; Group III, patients with one or both VAOs but no CCO.
aAdjusted for hypertension and coronary artery disease.
bAdjusted for hypertension, symptomatic status (stroke), and coronary artery disease.
Table V. Logistic regression analysis of risk factors for postprocedural stroke alone
Variable Reference of comparison
CEA (n ¼ 9; 1.3%) CAS (n ¼ 31; 6.8%)
OR (95% CI) P OR (95% CI) P
Presenting symptom
Strokea Asymptomatic 7.101 (1.718-29.344) .007 1.413 (0.659-3.030) .375
Status of contralateral carotid and vertebral artery
Group IIb Group I 5.186 (0.502-53.600) .167 0.570 (0.129-2.521) .459
Group IIIb Group I 3.495 (0.787-15.514) .100 1.273 (0.494-3.279) .617
CAS, Carotid artery stenting; CEA, carotid endarterectomy; CI, conﬁdence interval; OR, odds ratio.
Group I, Patients without CCO or VAO; Group II, patients with CCO with or without VAO; Group III, patients with one or both VAOs but no CCO.
aAdjusted for hypertension and coronary artery disease.
bAdjusted for hypertension, symptomatic status (stroke), and coronary artery disease.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 3 Yang et al 753stroke alone in CEA and CAS patients. On a comparison of
patient characteristics among the groups, we found that
stroke was signiﬁcantly less frequent in presenting symp-
toms in CEA patients in Group II. We do not know the
reason why stroke was less common in Group II. One
possible explanation is that patients with major stroke
due to CCO were already eliminated from the candidates
for CEA.
This retrospective analysis found signiﬁcantly higher
frequencies of ESNCs after CAS when compared with
CEA. And ESNCs were more frequently developed in
patients with CCO (compared with patients with patent
contralateral carotid artery) and patients who presented
with stroke (compared with an asymptomatic patient
group) in the CEA patients. However, CCO was not
a risk factor for the development of ESNC in the CAS
group. When we compared frequency of postprocedural
stroke alone, CCO or VAO showed no adverse impact
on the development of postprocedural stroke after CEA
or CAS. Regardless of contralateral carotid or vertebral
artery patency, ESNC or stroke developed more frequently
after CAS compared with CEA.
Recent studies have reported that the vast majority of
asymptomatic carotid stenosis will have a very low chance
of cerebrovascular event. The annual risk of stroke for
patients with greater than 50% carotid stenosis has been
decreasing over the past 20 years.16,17 A systematic
review18 reported that “non-interventional therapy is saferthan CEA/CAS and is three to eight times more cost-
effective,” questioning any beneﬁt of intervention for
asymptomatic patients. On the contrary, a recent report
from a Harvard group reported that optimal medical treat-
ment failed to prevent carotid disease progression or devel-
opment of ipsilateral symptoms in 45% of the patients with
asymptomatic carotid stenosis of moderate degree (50%-
69%).19
Given the uncertain efﬁcacy of CAS on asymptomatic
patients, we found that too many patients with asymptom-
atic carotid stenosis were treated with CAS in our patients.
However, it is hard to consider that CAS for patients with
asymptomatic carotid stenosis had an inﬂuence on our
study results.
In symptomatic patients, NASCET investigators7 re-
ported a higher rate (relative risk, 2.2; 95% conﬁdence
interval [CI], 1.1-4.5) of perioperative stroke after CEA
in patients with CCO compared with patients with patent
contralateral carotid artery. Antoniou et al8 reported
a meta-analysis report based on 28,846 CEAs, which
described increased incidence of early postoperative
(<30 days) stroke (odds ratio [OR], 1.65; 95% CI, 1.30-
2.09), TIA (OR, 1.57; 95% CI, 1.11-2.21), stroke/TIA
(OR, 1.52; 95% CI, 1.21-1.90), and death (OR, 1.76;
95% CI, 1.19-2.59) in patients with CCO compared with
patients without CCO. Other authors also reported
a higher frequency of perioperative stroke in patients with
CCO based on a meta-analysis.4,5
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stroke alone after CEA or CAS by categorizing patients
into three groups according to the presence or absence of
CCO and/or VAO. Our observations show presence of
CCO was an independent risk factor for composite end
point of ESNC in CEA patients but not for postprocedural
stroke alone in CEA or CAS patients.
During carotid clamping, the Circle of Willis can
provide a collateral channel to the contralateral hemi-
sphere in patients with CCO. Lee et al20 reported that
an incomplete posterior Circle of Willis was associated
with more common development of cerebral ischemia
associated with carotid clamping in patients with CCO.
According to them, an incomplete Circle of Willis had
no predictive value in patients with a patent contralateral
carotid artery.
Vertebro-basilar circulation constitutes 30% of cerebral
perfusion and one-quarter of ischemic strokes that develop
in the vertebro-basilar territory.21 Physiologically, hemody-
namic parameters can be changed in patients with uni- or
bilateral extracranial carotid occlusion.22 Nicolau et al23
described a compensatory increase in peak systolic velocity
and blood volume in the vertebral artery in patients with
unilateral internal carotid artery occlusion. Hoffman
et al13 also described that severe stenosis (>80%) of verte-
bral arteries increased the risk of 30-day stroke rate and
mortality rate in patients who underwent CEA. A retro-
spective analysis of CEA results in patients with CCO
and/or VAO described that the presence of CCO
increased the requirement for a carotid shunt during
CEA but did not increase early complication rates.12
In the present study, uni- and multivariate analyses
showed that unilateral or bilateral VAO (Group III) was
not an independent risk factor for ESNC or postprocedural
stroke in the CEA or CAS groups.
Regarding the impact of CCO in CAS patients, Sabeti
et al24 reported that contralateral high-grade carotid artery
stenosis or occlusion was not associated with increased risk
for poor neurologic outcome after elective CAS. In patients
with CCO, they described theoretical advantages of CAS
over CEA, which included short carotid occlusion time
and lack of general anesthesia during CAS. Other authors
also reported that CAS resulted in no signiﬁcant increases
in perioperative or long-term complications for patients
with CCO.25,26
On the contrary, Mercado et al27 reported that CCO
was associated with an increased risk of early postproce-
dural death, myocardial infarction, or stroke in patients
undergoing elective CAS, which was based on results
from the Carotid Artery Revascularization and Endarterec-
tomy (CARE) registry. Brewster et al28 recently reported
that CAS was not superior to CEA for early and midterm
outcomes in patients with CCO. They concluded that
CCO is not a clinically important reason for choosing
CAS in treatment of patients with CCO.
As described above, literature review of CAS outcomes
for patients with CCO yielded mixed results. In patients
with CCO or VAO, the risk of cerebral embolization tothe occluded contralateral carotid or vertebral artery can
be disregarded. However, tolerance to ipsilateral cerebral
embolization can be diminished in patients with CCO
or VAO.
CONCLUSIONS
In summary, we found a three-fold higher risk of
ESNCs following CAS compared with CEA. Particularly,
the risk of ESNCs was signiﬁcantly higher (about four-
fold) after CEA in patients with CCO than in those
without CCO. However, the increased risk of ESNC after
CEA in Group II patients was still lower than that of CAS.
When we analyzed the risk factors for postprocedural
stroke alone, presenting symptom of stroke was the only
risk factor, whereas CCO or VAO was not a risk factor.
Limitations of our study included biases caused by the
retrospective study design, inconsistent indications for CAS
and CEA, possible type II error due to relatively small
numbers in Group II and III, and the lack of complete
assessment of Circle of Willis.
In conclusion, CAS was followed by a signiﬁcantly
higher frequency of ESNC and postprocedural stroke
compared with CEA. By subgroup analysis, CCO was
a risk factor for ESNC but not for postprocedural stroke
alone in patients undergoing CEA. Unilateral or bilateral
VAO was not associated with a higher rate of ESNC or
stroke in CEA or CAS.
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